Pharmacy Market

Analysis by Product (Prescription, and OTC); by Pharmacy Type (Retail Pharmacy, and e-Pharmacy); and by Application (Hospital Grade, and Personal Use) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

Buy Now
Report ID: 4435 | Published On: Feb 13, 2023
Request Free Sample Copy

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Get more information on this report: Request Sample PDF

Global Pharmacy Market: Growth Drivers and Challenges

Growth Drivers

  • Rising Geriatric Population – Growing age have a significant impact on the likelihood of developing certain medical disorders. Numerous health problems that regularly plague the elderly people have a negative impact on their general quality of life. Thus, swiftly increasing geriatric population is leading the pharmacy market growth. According to the World Health Organization (WHO), there were approximately 1 billion people aged 60 and older in 2019. This number is expected to increase by nearly 1.4 billion by 2030 and 2.1 billion by 2050.

  • Worldwide Escalation in Chronic Diseases – For instance, the probability of developing a chronic disease was increased by 59% by 2020.

  • Upsurge in Autoimmune Disorders – For instance, all autoimmune diseases affect approximately 4% of the US population, that denotes nearly 10 million people in the region.

  • Surge in Approved Prescription Drugs – For instance, in the United States, more than 20,000 prescription drugs had approved for selling until 2020.  

  • Global Increase in Healthcare Expenditure - As per the World Bank data, global healthcare expenditure was expanded by 9.83% in 2019.


  • Hurdles Associated with the Use of Vaccines and Drugs
  • Stringent Policies of Government
  • Product Recalls and Lawsuit Filing Threat

The global pharmacy market is segmented and analyzed for demand and supply by product into prescription, and OTC, out of which the prescription segment is projected to significantly grow over the forecast period on the back of the globally increasing burden of chronic diseases i.e., cancer, diabetes, and significantly growing geriatric population. According to the World Health Organization (WHO), there are nearly 422 million diabetics worldwide, and diabetes is the leading cause of 1.5 million annual fatalities.

Global Pharmacy Market Regional Synopsis

Regionally, the global pharmacy market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2033 backed by the existence of major international pharmacy chains, significantly growing use of over-the-counter prescription drugs, rise in chronic disorders, rapidly growing geriatric population, and expanding healthcare expenditure in the region. For instance, in the United States, approximately 9 out of 10 people use OTC medications on regular basis, which is amounting more than 261 million users.


The global pharmacy market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global pharmacy market includes the following segments:

By Product

  • Prescription
  • OTC

By Pharmacy Type

  • Retail Pharmacy
  • e-Pharmacy

By Application

  • Hospital Grade
  • Personal Use

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Global Pharmacy Market

    • CVS Health Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Walmart Inc.
    • Walgreens Boots Alliance, Inc.
    • The Kroger Co.
    • Rite Aid Corp.
    • UnitedHealth Group
    • Well Pharmacy
    • Albertsons Companies, Inc.
    • LloydsPharmacy Limited
    • Cigna


In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the pharmacy market?

Ans: Rising geriatric population, worldwide escalation in chronic diseases, upsurge in autoimmune disorders, and surge in approved prescription drugs are some major factors driving the growth of the market.

2) What would be the CAGR of pharmacy market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 – 2033.

3) What are the challenges affecting the pharmacy market growth?

Ans: Hurdles associated with the use of vaccines and drugs, stringent policies of government, and product recalls and lawsuit filing threat are estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of pharmacy market in future?

Ans: The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

5) Who are the major players dominating the pharmacy market?

Ans: The major players in the market are CVS Health Corporation, Walmart Inc., Walgreens Boots Alliance, Inc., The Kroger Co., Rite Aid Corp., and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the pharmacy market?

Ans: The market is segmented by product, pharmacy type, application, and by region.

8) Which segment captures the largest market size in product segment in the pharmacy market?

Ans: The prescription segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample